Search This Blog

Monday, December 20, 2021

Novavax: EU Recommends Conditional Marketing Authorization of COVID Vaccine

 

  • European Commission decision on conditional marketing authorization expected imminently

  • Upon authorization, Nuvaxovid™ (also known as NVX-CoV2373) will be the first protein-based COVID-19 vaccine available in Europe

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)